Chronic inflammation is a known risk factor for the development of cholangiocarcinoma; STAT3 is involved in signaling pathways associated with inflammation, and its activation may contribute to the inflammatory microenvironment that promotes tumorigenesis [60]. This evidence concerns the gene STAT3 and cholangiocarcinoma.